2005
DOI: 10.1097/01.wnf.0000186651.96351.2e
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Levodopa on Healthy Volunteers' Facial Emotion Perception

Abstract: These results suggest that administration of levodopa to healthy volunteers directly or indirectly impairs the amygdalar activation during the emotional perception task. The authors hypothesized that amygdala activation may conform to an inverted U-shaped function in relation to changing dopamine levels.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
22
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(25 citation statements)
references
References 38 publications
3
22
0
Order By: Relevance
“…For example, administration of D-amphetamine boosts amygdalar reactivity to fearful and angry facial expressions, which fits nicely with the finding that dampened amygdalar reactivity in hypodopaminergic Parkinson patients can be restored back to normal levels by administering L-DOPA Tessitore et al, 2002;Kawamura and Kowayakaba, 2009). In sharp contrast, however, administration of L-DOPA and D-amphetamine has also been found to dampen aversive emotional reactions such as amygdalar reactivity to fearful faces and fear-potentiated startle to unpleasant stimuli (Delaveau et al, 2005(Delaveau et al, , 2007(Delaveau et al, , 2009Corr and Kumari, 2013). This apparent inconsistency may be clarified when considering that increasing DA activity through pharmacological interventions only has anxiogenic effects in high-anxiety individuals, whereas in low-anxiety subjects, the same DA increase has an anxiolytic effect (Mizuki et al, 1997).…”
Section: Serotonin X Dopamine Interactions: Explaining Interhemisphermentioning
confidence: 81%
“…For example, administration of D-amphetamine boosts amygdalar reactivity to fearful and angry facial expressions, which fits nicely with the finding that dampened amygdalar reactivity in hypodopaminergic Parkinson patients can be restored back to normal levels by administering L-DOPA Tessitore et al, 2002;Kawamura and Kowayakaba, 2009). In sharp contrast, however, administration of L-DOPA and D-amphetamine has also been found to dampen aversive emotional reactions such as amygdalar reactivity to fearful faces and fear-potentiated startle to unpleasant stimuli (Delaveau et al, 2005(Delaveau et al, , 2007(Delaveau et al, , 2009Corr and Kumari, 2013). This apparent inconsistency may be clarified when considering that increasing DA activity through pharmacological interventions only has anxiogenic effects in high-anxiety individuals, whereas in low-anxiety subjects, the same DA increase has an anxiolytic effect (Mizuki et al, 1997).…”
Section: Serotonin X Dopamine Interactions: Explaining Interhemisphermentioning
confidence: 81%
“…The amygdala is partially controlled by the brain's dopamine system (Delaveau et al 2005), as an essential part of the brain-reward circuitry-the same system that responds to alcohol and produces feelings of pleasure when good things happen (Koob 2003). In a recent study using fMRI in our laboratory ), we observed clear evidence of differences between abstinent long-term alcoholics and nonalcoholic controls in amygdala activation to emotional materials.…”
Section: Neural Systems Affected and Concomitant Neurobehavioral Defimentioning
confidence: 89%
“…We hypothesized that nondemented, nondepressed patients would show intact performance during an emotional processing task but that levodopa medication would overdose limbic regions and so disrupt normal amygdala functioning, as it does in healthy subjects. 2,3 …”
mentioning
confidence: 98%
“…1Y3 In 2 previous studies, we showed that levodopa administration in healthy subjects (temporary DA overdose status) led to a decreased amygdalar activation during emotional faces processing. 2,3 In Parkinson disease (PD), DA denervation progresses from dorsal regions (first the putamen then the caudate) to the ventral striatum. 4,5 Therefore, PD patients may present different neurocognitive changes as a function of the degree of DA depletion in these different regions.…”
mentioning
confidence: 99%